News

Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics — exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication approved for use against the virus.

The hope is that PROTACs can treat other “undruggable” cancers that don’t respond to current treatments, including types of lung, breast, and colorectal cancers that may not have an active site on which a small-molecule drug or monoclonal antibody could bind.

Our bodies have two immune systems: the innate and the adaptive, which is prompted into action by the innate immune system. Instead of relying solely on the adaptive immune system, two Yale Cancer Center scientists have gone upstream.

The fellows largely represented communities that have been historically unrepresented in the field of medical research, including those from ethnic and racial minorities, those with disabilities, those from low socioeconomic backgrounds, women, or those who identify as LGBTQI+.

COVID Research Funding Crucial For Junior Investigators

Roy Herbst, MD, PhD, Is Recognized for 25 Years of Lung Cancer Clinical Research

Yale School of Medicine (YSM) Assistant Professors of Immunobiology Carrie Lucas, PhD, and Aaron Ring, MD, PhD, recently received Young Investigator Awards from the International Cytokine & Interferon Society (ICIS).

Yale Cancer Center held its annual Conclave award ceremony virtually on January 26th to celebrate faculty and provider accomplishments 2020. Faculty and staff were honored with clinical and research prizes including the Ruth McCorkle Oncology Advanced Practice Provider Award, the Class of ‘61 Cancer Research Award, and the Yale Cancer Center Lifetime Achievement Award.

Chrystal Starbird, a postdoctoral fellow who works in the Ferguson Lab at the Yale Cancer Biology Institute, recently won the first Cell Press Rising Black Scientists Award. Her winning essay detailing her experiences as a person from an underrepresented group in science will be published in the February issue of the journal Cell.